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SUMMARY
The cerebral and systemic kinetics of intravenous thiopentone (250 mg over 2 minutes, n=5) and propofol (100 mg
over 2 minutes, n=6) were determined in sheep anaesthetized with halothane (2.0%) and mechanically ventilated to
an end-expired carbon dioxide tension of 40 mmHg. The sheep were previously instrumented with arterial and sagittal
sinus (effluent from the brain) blood sampling catheters. Systemic kinetics were inferred from the time-course of the
arterial blood concentrations, and cerebral kinetics from the time-course of the arterio-sagittal sinus concentration
difference across the brain. Under halothane anaesthesia, the peak arterial concentrations of each drug occurred at
the end of the two-minute infusion, and was 42.3 mg/l and 12.3 mg/l for thiopentone and propofol, respectively.
Propofol had a significantly larger systemic clearance (3.19 l/min) than thiopentone (0.99 l/min). The brain
concentrations of propofol equilibrated more slowly with the arterial concentrations than those of thiopentone. The
extraction ratio across the brain near the end of the infusions (1.5 min) were 0.85 and 0.46 respectively. These data
were also compared to analogous previously published data for initially conscious sheep. The systemic kinetics of
thiopentone were little affected by halothane anaesthesia. For propofol, halothane anaesthesia was associated with a
statistically significant reduction in clearance (50% of awake), a slower initial half-life (247% of awake), and the
emergence of a second slower half-life in some sheep. The cerebral kinetics of both drugs were subtly altered by
halothane anaesthesia.
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There is a large body of evidence documenting the
effect of general anaesthesia on drug disposition1.
Major perturbations can include altered cardiac
output and regional blood flows, and depression of
the activity of drug-metabolizing enzymes. While
pharmacokinetic studies of drugs ideally should be
conducted in conscious individuals, more complex,
invasive studies must be conducted in anaesthetized
animal preparations. Furthermore, for those drugs
commonly administered in the peri-operative period,
it is desirable to have some understanding of 
their kinetics in both conscious and anaesthetized
individuals.
We have previously reported a series of studies of
the cerebral kinetics of thiopentone and propofol in
halothane-anaesthetized sheep in which cerebral
blood flow was altered by changing arterial carbon
dioxide tension2. Cerebral kinetics were measured at
low, normal and high states of cerebral blood flow,
but only data for the low and high flow states were
analysed.  These were the most suitable data sets with
which to discriminate between various models of the
cerebral kinetics of these drugs. However, the pre-
viously unpublished measurements for the normal
cerebral blood state in these studies are of interest for
another reason, as the arterial carbon dioxide tension
(40 mmHg) is directly comparable to that of con-
scious animals. With the exception of the presence of
halothane anaesthesia, these were studies identical
with respect to dose, duration of injection and blood
sampling regimen to previously published studies of
the cerebral kinetics of thiopentone3 and propofol4 in
initially conscious sheep. In this paper we therefore
report these new data measured under halothane
anaesthesia, and compare them to previously pub-
lished data for initially conscious sheep.  The systemic
kinetics of thiopentone and propofol in sheep will
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also be examined in more detail. These new data will
contribute to an understanding of the mechanisms
governing the systemic and cerebral kinetics of these
agents, and their perturbation by halothane, and 
will also provide insight into whether halothane-
anaesthetized experimental preparations can be used




The experimental conditions have been reported
previously2. In summary, female Merino sheep of
similar ages and body mass (approximately 50 kg)
were used, and were instrumented under general
anaesthesia.  Catheters were chronically implanted in
the carotid artery (for sampling of arterial blood), in
the right atrium (for drug administration), and in the
dorsal sagittal sinus (the appropriate site for sampling
cerebral venous blood in sheep5). A Doppler trans-
ducer was placed over the sagittal sinus using a pre-
viously validated method to provide an index of
cerebral blood flow5. The sheep were recovered from
anaesthesia and housed in metabolic crates, with
their catheters continuously flushed with heparinized
saline.  All experimental protocols were approved by
the Animal Ethics Committee of the University of
Adelaide.
Study Design
At a later date, the sheep were again anaesthetized
(halothane, 2.0% inspired), intubated and mechani-
cally ventilated. For the thiopentone studies, anaes-
thesia was induced with intravenous propofol 
(200 mg): for the propofol studies they were induced
with intravenous thiopentone (1000 mg). Blood pres-
sure was monitored throughout the anaesthetic and
maintained near the baseline value with infusions of
normal saline as necessary. After waiting at least 1.5
hours, which previous work has shown was sufficient
for the induction agent to reach insignificant concen-
trations in blood3,4, ventilation rate was adjusted to
give an end expired carbon dioxide tension (PETCO2
of 40 mmHg Model OIR 7101, Nihon Kohden
Corporation, Tokyo, Japan). Once PETCO2 had stabi-
lized, either thiopentone (250 mg over 2 min) or
propofol (100 mg over 2 min) were infused intra-
venously. Arterial blood (0.5 ml) was sampled at 0.25,
0.5, 0.75, 1, 1.25, 1.5, 1.75, 2, 3, 4, 5, 6, 8, 10, 12.5, 15,
17.5 and 20 minutes after the start of the infusion,
Sagittal sinus samples (0.5 ml) were taken at 0.5, 1,
1.5, 2, 3, 4, 5, 6, 8, 10, 12.5, 15, 17.5 and 20 minutes.
All times are hereafter referenced to the start of the
two-minute infusions.
At the end of the study, the sheep were recovered
from anaesthesia and returned to their metabolic
crate. The study design was a “cohort” study, with
thiopentone studied in five different sheep and
propofol in six different sheep. One sheep was
common to both the thiopentone and propofol
studies.
Drug Analysis
All drug concentrations were determined as whole
blood concentrations. Thiopentone samples were
assayed using a method based on protein precipita-
tion and separation using a high pressure liquid
chromatograph with UV detection as previously
described3. The limit of quantification was approxi-
mately 0.1 mg/l. Propofol samples were assayed using
a previously described method4 based on basic extrac-
tion and separation using a high pressure liquid
chromatograph with fluorescence detection. The
limit of quantification was approximately 0.02 mg/l.
For each drug, standard curves were prepared with
concentrations that spanned the expected concentra-
tion range in drug-free blood taken prior to drug
administration. The level of precision of both assays
was such that the r2 value for linear regression of the
standard curve was more than 0.995 in all cases.
Data Analysis
Systemic kinetics
Systemic kinetics were inferred from the time-
course of the arterial drug concentrations. These
were described in terms of 
1. the peak concentration achieved, 
2. the area under the concentration time curve
(AUC) determined by trapezoidal integration with
extrapolation to infinity of the terminal exponential
phase, 
3. systemic clearance as given by AUC over total
dose. 
The post infusion decline in concentrations were
also fitted to single exponential or bi-exponential
equations using the “Scientist for Windows” model-
ling program (Micromath Scientific Software, Utah,
U.S.A.). The rate constants of these exponentials
were expressed as half-lives. Fitting a single exponen-
tial equation to the data produced one half-life term,
while a bi-exponential produced two (fast and slow)
half-life terms.
The equivalent analysis was also performed on pre-
viously published arterial concentration data for the
same dose of thiopentone3 and propofol4 in initially
conscious sheep.
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Cerebral kinetics
The uptake and elution of the drugs in the brain
were described in a model independent manner by
calculating the extraction ratio (E) of each drug
across the brain at times representative of the intra-
infusion period (1.5 min) and the immediate post-
infusion period (3 min). The following formula was
used, where Cart and Csag were the arterial and




Cerebral kinetics were also examined using hybrid
modelling, which describes cerebral kinetics inde-
pendently of any influence of the time-course of the
arterial concentrations entering the brain. The details
of this method have been described previously2. The
arterial concentrations entering the organ were fitted
to empirical forcing functions that closely matched
the observed data. These were used as input functions
for the model of cerebral kinetics—the parameter
values for the model were then estimated by curve-
fitting the sagittal sinus concentrations in blood
emerging from the brain. Two models of cerebral
kinetics were examined—a membrane limited 
model, and a single flow-limited compartment model
(Figure 1). As the true value of cerebral blood flow
was not known (the method used only measures
relative changes in flow within an animal), cerebral
blood flow was incorporated as an unknown term into
the parameters of the models (Figure 1).
Statistical Analysis
The general method used for statistical analysis
was based on the calculation of the appropriate mean
value and its upper and lower 95% confidence inter-
vals assuming a t-distribution6. T-tests were also used
to compare kinetic parameters between the awake
and halothane anaesthetized states.
RESULTS
The mean PETCO2 at the start of the propofol
infusions in halothane anaesthetized sheep was 41.5 
(SD 10.6) mmHg, which was comparable to the
measured peak arterial partial pressure in the initially
conscious sheep of 41 mmHg7.
The arterial and sagittal sinus (effluent from the
brain) blood concentrations measured under halo-
thane anaesthesia are shown in Figure 2—both drugs
reached their peak arterial concentration at the end
of the two minutes infusion.
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FIGURE 1: Schematic representations of the models of cerebral
kinetics fitted to the data. Upper: Membrane limited model. The
model has 2 compartments—a “vascular compartment” into which
drug is delivered via arterial blood (Cart) and leaves via sagittal
sinus blood (Csag), as governed by the rate constant k1 (min–1).
Drug can also enter and leave a deeper compartment via rate con-
stants k2 and k3, respectively (also min–1). These three rate 
constants were the fitted parameters. They can also be defined 
in terms of cerebral blood flow (Q), and volumes of the two 
compartment (Vc and Vdeep, respectively): k1=Q/Vc; k2=PS/Vc;
k3=PS/Vdeep, where PS is the permeability term (l/min) for the
membrane barrier. Lower: Single-flow limited compartment
model. This is analogous to the above model without the deep
compartment.
FIGURE 2: The mean arterial and sagittal sinus concentrations of
thiopentone (upper panel) and propofol (lower panel) observed
when doses of 250 or 100 mg, respectively, were infused intra-
venously over 2 min to halothane anaesthetized sheep. Data are
shown as mean and standard error.
Systemic kinetics
The parameters describing the arterial concentra-
tions under halothane anaesthesia are summarized in
Table 1. Thiopentone showed a bi-exponential decline
in concentration after the infusion. While three of six
propofol studies showed a bi-exponential decline, the
remainder showed a rapid mono-exponential decline.
Propofol had a significantly larger systemic clearance
than thiopentone.
For comparison, the analogous data for the pre-
viously published conscious studies are also shown in
Table 1.  There were no statistically significant dif-
ferences in the systemic kinetics of thiopentone
between halothane anaesthetized and initially con-
scious sheep. For propofol, halothane anaesthesia
was associated with a statistically significant reduc-
tion in clearance (50% of awake), a slower initial half-
life (247% of awake), and the emergence of a second
half-life in some sheep that was not present in the
initially conscious group.
Cerebral kinetics
The intra-infusion and post-infusion extraction
ratios of thiopentone and propofol across the brain
under halothane anaesthesia are shown in Table 2.
Both drugs were characterised by uptake into the
brain during the infusion (positive extraction ratio).
In keeping with previous observations, the brain
concentrations of propofol equilibrated more slowly
with the arterial concentrations than those of
thiopentone, with the extraction ratio for propofol
being almost twice that of thiopentone. For both
drugs, uptake turned to elution within 1 to 2 minutes
after the end of the infusion period (negative
extraction ratio).
The analogous extraction ratio data for the pre-
viously published studies in initially conscious sheep
are also shown in Table 2. There were no differences
in extraction between the two groups during the infu-
sion, but halothane anaesthesia was associated with a
significantly less elution (i.e., more positive extraction
ratio) in the immediate post-infusion period.
Such differences in the model independent analysis
of cerebral uptake, while relatively subtle, were
reflected in the hybrid modelling of cerebral kinetics
(Table 3). Under halothane anaesthesia, both the
thiopentone and propofol data were fitted better by
the membrane-limited model. The awake thio-
pentone data was better described by the single flow-
limited compartment model. Therefore, for thio-
pentone, halothane anaesthesia was associated with
an increase in turnover in the deep compartment,
such that it collapsed to single compartment. In
contrast, while the awake propofol data was better
described by a membrane-limited model, the confi-
dence intervals of the parameters of the membrane-
limited models were significantly different between
the awake and halothane anaesthetized groups.
Halothane anaesthesia was associated with a smaller
deep distribution volume (k3/k2=1.1 vs 1.35) and
more rapid turnover in the deep compartment (1/k3
=1.51 vs 8.2 min).
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TABLE 1
Summary of systemic kinetic parameters
Thiopentone Halothane Awake (n=6)
(n=5)
Peak Conc (mg/l) 42.3 40.8
(30.1-54.5) (29.4-52.2)
AUC (mg/l/min) 278 317
(142-412) (205-428)
CI (l/min) 0.99 0.87
(0.62-1.37) (0.56-1.18)
Fast t1/2 (min) 0.97 0.43
(0.14-1.80) (0.33-0.53)
Slow t1/2 (min) 9.3 8.8
(5.9-12.8) (6.6-11.1)
Propofol Halothane Awake (n=5)
(n=6)
Peak Conc (mg/l) 12.3 9.5
(8.5-16.1) (6.4-12.6)
AUC (mg/l/min) 35.0* 16.6
(21.2-48.7) (11.3-21.8)
CI (l/min) 3.19* 6.36
(1.99-4.39) (4.38-8.33)
Fast t1/2 (min) 0.84* 0.34
(0.49-1.19) (0.26-0.42)
Slow t1/2 (min) 3.6, 7.0, 5.8 na
Data are given as mean and 95% confidence intervals.
*Significantly different from awake, by t-test. 
TABLE 2
Intra-infusion (1.5 min) and post-infusion (3 min) extraction ratios
of thiopentone and propofol across the brain
Thiopentone Halothane Awake (n=6)
(n=5)
1.5 min 0.46 0.45
(0.08) (0.07)
3 min –0.01* –0.20
(0.06) (0.13)
Propofol Halothane Awake (n=5)
(n=6)
1.5 min 0.85 0.84
(0.05) (0.12)
3 min 0.42* –0.83
(0.15) (0.38)
Data are given as mean and standard deviation.
*Significantly different from awake, by t-test.
DISCUSSION
This study reports the systemic and cerebral
kinetics of thiopentone and propofol under
halothane anaesthesia, and an opportunistic com-
parison with conscious data. Limitations of the ex-
perimental design therefore include the fact that 
it was not a random cross-over study. However,
previous experience has shown that the kinetics 
of drugs in sheep are relatively reproducible3,4.
Furthermore they represent a relatively homo-
geneous study population as they were from the same
flock and were of similar age and weight. In addition,
the experimental design was not ideal for elucidating
the mechanisms of the interaction of halothane with
thiopentone or propofol, as the relative changes in
key determinants of kinetics such as cardiac output
and cerebral blood flow were not measured. Never-
theless, these data are valuable in that they document
the magnitude of the interaction, and together with
published literature, can be used to make some in-
ferences about the mechanisms governing the 
effect of halothane on the kinetics of intravenous
anaesthetics.
The systemic kinetics of thiopentone were little
affected by halothane, while those of propofol were
characterized by higher peak concentrations, a larger
AUC and lower total clearance. Recent work has pro-
vided some insight into the determinants of the peak
arterial concentrations achieved after an intravenous
bolus or short infusion administration of a drug9. 
For drugs with a relatively high clearance, the first
pass concentrations contribute significantly to the
observed arterial concentrations—these in turn are a
function of first-pass dilution with cardiac output and
the kinetics of the drug in the lungs. A low cardiac
output will produce higher peak concentrations—this
has been shown experimentally for propofol9, and via
modelling analysis for thiopentone10,11 and propofol12.
Although cardiac output was not measured in the
present study, the effect of halothane anaesthesia on
cardiac output is well defined. In sheep, 1.5%
halothane (albeit in the presence of other drugs)
lowered cardiac output to 71% of control at 30 min
after induction13. Higher concentrations of halothane
markedly reduced cardiac output14. However, as the
duration of anaesthesia increases there is a tendency
for cardiac output to return to control values13. In the
present study, measurements were made at least 1.5 h
after the start of halothane anaesthesia. This, and the
fact that the systemic kinetics of thiopentone were
unchanged compared to awake, suggest that cardiac
output was unaltered between the awake and
halothane anaesthetized group at the time of the drug
infusion. This being the case, a mechanism other than
lowered cardiac output would need to be invoked 
to explain the higher peak propofol concentrations
observed under halothane anaesthesia. It has pre-
viously been reported that propofol was extracted
across the lungs of initially conscious sheep in a non-
linear manner (i.e., the extraction was reduced or
abolished at higher propofol concentrations15), and
that propofol has a high first pass lung clearance in
sheep16. The observed changes in systemic kinetics of
propofol under halothane anaesthesia (higher peak
concentrations, higher AUC and lower clearance) are
consistent with this lung extraction being reduced or
abolished. Reductions in hepatic clearance, although
often associated with halothane anaesthesia, are
known to have only a minor impact on the initial
concentrations of these drugs after short infusion
administration12.
The cerebral kinetics of both drugs under
halothane anaesthesia differed subtly from those
measured in initially conscious sheep. This was
apparent for the model-independent analysis, which
showed that halothane affects the elution of thio-
pentone and propofol in the brain more than their
uptake. However, extraction ratio is a relatively crude
measure of organ kinetics, as its magnitude depends
on the time-course of the arterial drug concentrations
entering the organ. Thus, it is possible to have
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TABLE 3
Parameter values for cerebral kinetic models
Thiopentone Propofol
Parameter and Halothane Awake Halothane Awake
model
Membrane-limited
MSC 4.50 2.97 4.24 3.22
k1 2.01 1.12 0.334 0.24
(1.20- (0.925- (0.251- (0.212-
2.82) 1.31) 0.418) 0.269)
k2 1.31 na 0.731 0.165
(–0.010- (0.115- (0.063-
2.64) 1.35) 0.267)




MSC 2.83 3.24 2.24 2.23
k1 1.07 1.11 0.181 0.197
(0.81- (0.937- (0.154- (0.172-
1.27) 1.29) 0.208) 0.222)
The MSC is the Model Selection Criterion of the modelling pack-
age used (Scientist for Windows). It is an adaption of the Akaike
Information Criterion, but in this case the higher value indicates a
better fit. The MSC of the best model of the two examined is shown
in bold. The parameters of the models (k1, k2 and k3) are as defined
in Figure 1. Data are given as best fit estimate of the parameter
with its 95% confidence intervals returned by the curve-fitting
program.
changes in extraction even when organ kinetics have
not changed, if there are differences in the systemic
kinetics of the drug. This was overcome by hybrid
modelling of the cerebral kinetics, which describes
cerebral kinetics independently of any influence of
the time-course of the arterial concentrations enter-
ing the brain. This confirmed that there were direct
changes in the cerebral kinetics of thiopentone and
propofol under halothane anaesthesia.
On first principles, these changes could be due to
either altered cerebral blood flow or altered cerebral
distribution volumes under anaesthesia. The influ-
ence of cerebral blood flow changes on the cerebral
kinetics of thiopentone and propofol have been
examined previously2. Although their rate of uptake
into the brain was consistent with slight membrane
limitation, the rate of equilibration of cerebral drug
concentrations with those in arterial blood was found
to increase with increased blood flow. Unfortunately,
comparative data on absolute cerebral blood flow in
conscious and halothane-anaesthetized sheep are not
available—the flow method used in the present study
measures relative blood flow within an animal.
However, when carbon dioxide tension is controlled
for (as in the present study) it has been found that
halothane anaesthesia increases cerebral blood flow
to approximately 150% of control values17,18. It is also
known that in contrast to isoflurane, halothane pro-
duces relatively homogeneous changes in cerebral
blood flow throughout regions of the brain19.
If cerebral blood flow was increased under
halothane anaesthesia to 150% of baseline in the
present study, this should be reflected in the k1 rate
constant of the membrane-limited model.  This was in
fact the case—k1 increased under halothane anaes-
thesia to 179% and 139% of awake values (Table 1)
for thiopentone and propofol, respectively. Thus, it
seems plausible that some of the changes in cerebral
kinetics can be explained by the altered cerebral
blood flow under halothane anaesthesia. However, it
is evident from the inconsistent changes in the other
parameters (k2, k3) that the effect of halothane anaes-
thesia is complex. These changes in cerebral kinetics
will not be fully understood until the physical nature
or mechanism of the apparent membrane limitation
in the cerebral kinetics of thiopentone and propofol is
better understood. In the interim, it should be con-
cluded that the differences in the cerebral kinetics of
thiopentone and propofol between the initially
conscious and halothane-anaesthetized states are
sufficiently large that one cannot be inferred from the
other. The possible interaction between the lung
kinetics of propofol and halothane also requires
further investigation as a mechanism for why the
systemic kinetics of propofol but not thiopentone
were affected by halothane anaesthesia.
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